From the Food and Drug Administration.
Schwetz
B A
BA
D009320:Atrial Natriuretic Factor / Q000627:therapeutic use*; D002316:Cardiotonic Agents / Q000627:therapeutic use*; D004164:Diphosphonates / Q000627:therapeutic use*; D017743:Equipment Reuse / Q000592:standards*; D006333:Heart Failure / Q000188:drug therapy*; D006801:Humans; D006934:Hypercalcemia / Q000188:drug therapy* / Q000209:etiology; D007093:Imidazoles / Q000627:therapeutic use*; D020097:Natriuretic Peptide, Brain; D009369:Neoplasms / Q000503:physiopathology; D014481:United States; D014486:United States Food and Drug Administration; D000077211:Zoledronic Acid
D002316:Cardiotonic Agents; D004164:Diphosphonates; D007093:Imidazoles; D020097:Natriuretic Peptide, Brain; D000077211:Zoledronic Acid; D009320:Atrial Natriuretic Factor